Latin America Wound Dressing Market Size, Segment Analysis and Forecast Report 2024
The LATAM wound dressing market is expected to reach $400.9 million by 2024. The market growth is primarily driven by growing geriatric population, rising prevalence of diabetes, high rate of brain injuries, and increasing number of patients with chronic wounds in the region.
Request for report sample at: https://www.psmarketresearch.com/market-analysis/latam-wound-dressing-market/report-sample
Based on type, the Latin American wound dressing market is bifurcated into advanced and traditional dressings. The category of advanced wound dressings is estimated to hold over 60.0% share in the market in 2018. This can be mainly ascribed to the growing use of these dressings in complex areas of application and the increasing prevalence of chronic diseases in the region. Advanced wound dressings are further classified into foams, hydrocolloids, films, alginates, hydrogels, collagen, hydrofiber, wound contact layers, superabsorbent, and other dressings. Among these, foam dressings are the most commonly used advanced dressings in the region and witness a high demand in the Latin American advanced wound dressing market.
Hospitals and specialty clinics; home healthcare; and long-term care settings are the major end users in the Latin American wound dressing market. Hospitals and specialty clinics, as an end-user category, hold the largest share in the regional market. The category is estimated to contribute 70.4% revenue to the market in 2018. This can be mainly ascribed to the presence of a vast patient pool in hospitals and clinics for the treatment of injuries.
Browse full report at: https://www.psmarketresearch.com/market-analysis/latam-wound-dressing-market
Some of the key players operating in the Latin American wound dressing industry are Hollister Incorporated; DeRoyal Industries Inc.; Johnson & Johnson; Smith & Nephew plc; Mölnlycke Health Care AB; 3M Company; Acelity L.P. Inc.; BSN Medical GmbH; HARTMANN GROUP; B. Braun Melsungen AG; and Coloplast A/S.
Source: P&S Intelligence
